Fluorine in PDB 6xp9: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1

Enzymatic activity of Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1

All present enzymatic activity of Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1:
2.3.1.48;

Protein crystallography data

The structure of Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1, PDB code: 6xp9 was solved by J.A.Khan, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.94 / 2.27
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 85.029, 88.613, 105.860, 90.00, 90.00, 90.00
R / Rfree (%) 19.5 / 22

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1 (pdb code 6xp9). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1, PDB code: 6xp9:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 6xp9

Go back to Fluorine Binding Sites List in 6xp9
Fluorine binding site 1 out of 2 in the Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F501

b:62.4
occ:1.00
F1 A:QCG501 0.0 62.4 1.0
C10 A:QCG501 1.4 62.1 1.0
C11 A:QCG501 2.3 61.1 1.0
C9 A:QCG501 2.4 62.9 1.0
H5 A:QCG501 2.6 69.4 0.0
O4 A:QCG501 2.7 60.7 1.0
C5 A:QCG501 3.6 64.1 1.0
C12 A:QCG501 3.6 61.4 1.0
CG A:MET246 3.9 41.7 1.0
OG A:SER247 3.9 48.9 1.0
O A:MET243 4.0 46.7 1.0
C28 A:QCG501 4.1 60.5 1.0
CB A:MET246 4.1 41.0 1.0
C13 A:QCG501 4.1 62.3 1.0
CA A:MET243 4.2 47.7 1.0
CB A:MET243 4.2 50.5 1.0
CG A:MET243 4.4 56.5 1.0
H27 A:QCG501 4.4 64.0 0.0
H28 A:QCG501 4.5 62.1 0.0
O3 A:QCG501 4.5 72.4 1.0
CE2 A:PHE288 4.6 40.4 1.0
C A:MET243 4.6 46.7 1.0
N A:SER247 4.6 40.5 1.0
CZ A:PHE288 4.7 39.9 1.0
C4 A:QCG501 4.8 66.7 1.0
C26 A:QCG501 4.9 60.6 1.0
C29 A:QCG501 4.9 60.4 1.0

Fluorine binding site 2 out of 2 in 6xp9

Go back to Fluorine Binding Sites List in 6xp9
Fluorine binding site 2 out of 2 in the Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-Activator Peptide in Complex with (S,S)-1 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F502

b:63.5
occ:1.00
F1 B:QCG502 0.0 63.5 1.0
C10 B:QCG502 1.4 63.9 1.0
C11 B:QCG502 2.4 62.9 1.0
C9 B:QCG502 2.4 64.9 1.0
H5 B:QCG502 2.6 75.0 0.0
O4 B:QCG502 2.7 61.9 1.0
C5 B:QCG502 3.6 66.0 1.0
C12 B:QCG502 3.6 63.1 1.0
O B:HOH621 3.6 68.4 1.0
CG B:MET246 3.8 43.8 1.0
O B:MET243 3.9 46.6 1.0
OG B:SER247 3.9 48.0 1.0
CB B:MET246 4.0 43.8 1.0
C28 B:QCG502 4.1 61.9 1.0
CA B:MET243 4.1 48.1 1.0
C13 B:QCG502 4.1 64.4 1.0
CB B:MET243 4.2 49.2 1.0
CG B:MET243 4.4 55.0 1.0
H27 B:QCG502 4.5 68.0 0.0
H28 B:QCG502 4.5 66.4 0.0
C B:MET243 4.5 47.4 1.0
N B:SER247 4.6 43.7 1.0
CE2 B:PHE288 4.6 41.2 1.0
CZ B:PHE288 4.7 40.9 1.0
O3 B:QCG502 4.7 73.1 1.0
C4 B:QCG502 4.8 68.4 1.0
C26 B:QCG502 4.9 62.4 1.0
C29 B:QCG502 4.9 62.1 1.0
H29 B:QCG502 4.9 65.7 0.0
C B:MET246 5.0 44.1 1.0

Reference:

P.Sivaprakasam, Z.Wang, N.A.Meanwell, J.A.Khan, D.R.Langley, S.R.Johnson, G.Li, A.Pendri, T.P.Connolly, M.Gao, D.M.Camac, C.Klakouski, T.Zvyaga, C.Cianci, B.Mcauliffe, B.Ding, L.Discotto, M.R.Krystal, S.Jenkins, K.M.Peese, B.Narasimhulu Naidu. Structure-Based Amelioration of Pxr Transactivation in A Novel Series of Macrocyclic Allosteric Inhibitors of Hiv-1 Integrase. Bioorg.Med.Chem.Lett. V. 30 27531 2020.
ISSN: ESSN 1464-3405
PubMed: 32890685
DOI: 10.1016/J.BMCL.2020.127531
Page generated: Sun Dec 13 13:37:41 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy